7-ALLYL-7 8-DIHYDRO-8-OXOGUANOSINE 95
CAS: 121288-39-9
Ref. IN-DA009ELU
1mg | 61,00 € | ||
5mg | 108,00 € | ||
10mg | 146,00 € | ||
25mg | 172,00 € | ||
50mg | 243,00 € | ||
100mg | 502,00 € |
Informação sobre produto
- 7-allyl-8-oxoguanosine
- 7a8oGuo
- loxoribine
- 7-allyl-8-oxoguanosine
- 7-Allyl-7,8-dihydro-8-oxoguanosine
- Guanosine, 7,8-dihydro-8-oxo-7-(2-propenyl)-
- Loxoribina
- Loxoribinum
- 2-Azanyl-9-[(2~{r},3~{r},4~{s},5~{r})-5-(Hydroxymethyl)-3,4-Bis(Oxidanyl)oxolan-2-Yl]-7-Prop-2-Enyl-1~{h}-Purine-6,8-Dione
- 7-Allyl-78-dihydro-8-oxoguanosine
- Ver mais sinónimos
- (Loxoribine)"
- 7-Allyl-2-amino-9-beta-D-ribofuranosylpurine-6,8(1H,9H)-dione
- 7-allyl-7,8-dihydro-8-oxo-guanosine
- 7-Allyl-7,8-dihydro-8-oxoguanosine, 95%
- 7,8-Dihydro-8-oxo-7-(2-propenyl)guanosine
- 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-(prop-2-en-1-yl)-6,7,8,9-tetrahydro-3H-purine-6,8-dione
- 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-enyl-3H-purine-6,8-dione
- 7-allyl-2-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purine-6,8(7H,9H)-dione
- 7-allyl-2-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purine-6,8(7H,9H)-dione
- 9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-amino-7-prop-2- enyl-1,7-dihydropurine-6,8-dione
- 7a8oGuo
- 7-Allyl-8-oxo-7,8-dihydroguanosine
- 7-(2-Propenyl)-8-oxo-7,8-dihydroguanosine
- 7,8-Dihydro-8-oxo-7-(2-propen-1-yl)guanosine
- 7-Allyl-8-oxoguanosine
- 8-Oxo-7-Prop-2-En-1-Ylguanosine
- Guanosine, 7,8-dihydro-8-oxo-7-(2-propen-1-yl)-
- Loxoribina [INN-Spanish]
- Loxoribine [USAN:INN]
- Loxoribinum [INN-Latin]
- Rwj 21757
- Unii-9Cas0V66Oi
Propriedades químicas
Consulta técnica sobre: IN-DA009ELU 7-ALLYL-7 8-DIHYDRO-8-OXOGUANOSINE 95
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.